| Authors: |
Sammons S; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. sarahl_sammons@dfci.harvard.edu., Yardley DA; Department of Medical Oncology, Sarah Cannon Research Institute, Nashville, TN, USA., Sharma P; Department of Internal Medicine, University of Kansas Medical Center, Westwood, KS, USA., Gadi VK; Division of Hematology and Oncology, University of Illinois Cancer Center, Chicago, IL, USA., Pegram M; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA., Pathak P; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Hu H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Sopher G; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA., Fasching PA; Gynecology and Obstetrics Translational Medicine, University Hospital Erlangen Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany. |
